Taiwan-based Bora Pharmaceuticals Co. has announced the appointment of J.D. Mowery to the newly created position of Division President of Bora’s CDMO business.

Mowery joins Bora Group from KBI Biopharma a JSR Life Sciences company, where he served as President and CEO and led global CDMO operations. He serves as a board member of AST, a technology leader specialising in advanced aseptic filling and closing systems, and was previously an Officer of JSR Corporation.

Mowery has also held roles of increasing responsibility at innovators such as Genentech, Treadwell Therapeutics, Juno Therapeutics, Celgene, and executive-level roles with CDMOs including Lonza and AGC Biologics.

His extensive experience includes operations, manufacturing, tech transfer, facility construction, business development, and investor relations, across North America, Europe, and Asia. Mowery holds a bachelor’s from George Fox University and an MBA from Marylhurst University.